On Sept. 25, 2025, the National Institutes of Health (NIH) announced the award of contracts for launching the…
On Sept. 17, 2025, GSK announced plans to invest $30 billion across the United States in research and…
On Sept. 9, 2025, Emergent BioSolutions announced that a contract modification has been executed in the amount of…
On Sept. 9, 2025, Elutia announced it has entered into a definitive agreement to sell its EluPro™ and…
On Sept. 4, 2025, Novavax announced a milestone payment from Takeda has been triggered by regulatory approval for Novavax’s…
On Aug. 27, 2025, Novavax announced that the U.S. Food and Drug Administration (FDA) has approved the Nuvaxovid™ 2025-2026…
On Aug. 20, 2025, two studies led by Johns Hopkins Kimmel Cancer Center, Ludwig Center, and Johns Hopkins Whiting School of…
On Jul. 22, 2025, AstraZeneca announces $50 billion of investment in the United States by 2030, building on…
On Jun. 16, 2025, Supernus Pharmaceuticals and Sage Therapeutics announced a definitive agreement for Supernus to acquire Sage…
On Jun. 11, 2025, Novavax announced results of the initial cohort of its COVID-19-Influenza Combination (CIC) and stand-alone trivalent…
On May 17, 2025, The U.S. Food and Drug Administration approved Novavax’s COVID-19 vaccine, but placed additional conditions…
On May 7, 2025, Gilead Sciences announced $11 billion in new planned investment in the U.S. to add…
On May 7, 2025, Howard Hughes Medical Institute Investigator Charles Zuker and members of his Columbia University lab…
On May 6, 2025, in a first-of-its-kind surgery, a multidisciplinary team led by a University of Maryland Medical…
On Mar. 15, 2023, scientists at Texas A&M announced that a research study: ‘RNA interference is essential to…
On Nov. 9, 2021, Howard Hughes Medical Institute announced a program, named Codetta, that can read the genome…
On Dec. 15, 2020, Aurinia Pharmaceuticals announced the funding and initiation of an open-label exploratory trial evaluating the…
On Nov. 1, 2020, the U.S. Department of Defense announced the start of rapid, on-site COVID-19 testing for…
On Aug. 14, 2020, Novavax announced it had signed a Heads of Terms (Term Sheet) with the Government…
On Aug. 7, 2020, scientists at Scripps Research announced they had obtained high-resolution, atomic-scale details of the structure…
On Jul. 27, 2020, FUJIFILM Diosynth Biotechnologies (FDB) and Texas A&M announced they mass will produce vaccines as…
On Jan. 19, 2017, PharmAthene and Altimmune, a privately-held immunotherapeutics company targeting infectious diseases, announced an agreement for…
On Oct. 1, 2015, The Kavli Foundation announced a $20 million award to establish the Kavli Neural Systems…
On Oct. 28, 2010, Emergent BioSolutions announced it had completed the acquisition of Seatte-based Trubion Pharmaceutical for upfront…
On Aug. 12, 2010, OriGene Technologies based in Rockville, Maryland, announced the acquisition of Blue Heron Biotechnology, a…
On May 20, 2010, researchers at the J. Craig Venter Institute in Maryland published results describing the successful…
In 2010, Hanger announced that it was relocating its corporate headquarters from Bethesda, MD to Austin, TX. In…
In 2008, the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCC) received NCI designation, a…
On Jan. 17, 2006, researchers at the University of California, San Diego (UCSD) announced the development of a…
On Dec. 1, 202, Sidney Kimmel, founder and chairman of Jones Apparel Group, donated $150 million for cancer…